Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Reduction is a fundamental chemical process characterized by the gain of electrons or a decrease in the oxidation state of a molecule, atom, or ion [1]. In biological systems, reduction is one half of a redox (reduction-oxidation) reaction and is essential for energy production, such as the transfer of electrons in the mitochondrial electron transport chain, and for biosynthetic pathways like fatty acid synthesis [2]. However, 'reduction' itself is a general chemical reaction mechanism and does not refer to a specific protein, receptor, or enzyme that can be pharmacologically targeted [1]. While many therapeutic drugs target specific enzymes that catalyze reduction reactions (such as HMG-CoA reductase or Dihydrofolate reductase), the process of reduction is too broad to be considered a discrete therapeutic target [3]. Consequently, this entry is classified as incorrect for a target-specific database as it describes a process rather than a biological macromolecule.
Not applicable as reduction is a chemical process, not a specific drug target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reduction.